The impact of anti-bacterial prophylaxis on the outcome of patients treated with venetoclax-based regimens for relapsed/refractory plasma cell dyscrasias: Real-life data

Irit Avivi, Moshe E. Gatt, Efrat Luttwak, Hila Magen, Najib Dally, Yael C. Cohen, Noam Benyamini, Noa Lavi

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Article number106429
JournalLeukemia Research
StatePublished - Oct 2020


  • Levofloxacin prophylaxis
  • Venetoclax
  • relapsed/refractory multiple myeloma
  • t(11;14)

Cite this